SecBot SecBot
SECBOTREPLAY Home › Report › OTLK

OTLK · Outlook Therapeutics raised approximately $5.0 million through a…

Outlook Therapeutics, Inc. · PRESS-RELEASE filed Apr 23, 2026 at 16:05 ET

At the news

BEARISHIMPACT 6/10

PRESS-RELEASE filed Apr 23, 2026 at 16:05 ET

Outlook Therapeutics raised approximately $5.0 million through a registered direct offering of 16.1 million shares at $0.31 per share, accompanied by a concurrent private placement of unregistered warrants to purchase an additional 16.1 million shares at $0.31. The company also amended existing warrants to lower their exercise price from $2.26 to $0.31, aligning them with the new offering. Proceeds will be used for working capital and general corporate purposes.

  • Raised $5.0 million gross proceeds via issuance of 16,129,033 shares at $0.31 per share.
  • Concurrent private placement of unregistered warrants to purchase up to 16,129,033 shares at $0.31 per share, exercisable upon stockholder approval and charter amendment.
  • Amended existing warrants for 2,142,854 shares, reducing exercise price from $2.26 to $0.31.
  • Total potential proceeds from fully exercised warrants: additional $5.0 million (no assurance of exercise).

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access